CMPS · Nasdaq · CIK 0001816590

COMPASS Pathways plc

COMPASS Pathways plc’s most recent SEC filing in our snapshot is a Form 144 filed on Aug 10, 2026. Its EDGAR record lists 17 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
—
Net income, FY2025
-$287.9M
Form 4 filings on record, past 12 months
17

Company overview

Legal name (as filed)
COMPASS Pathways plc
Ticker
CMPS
SEC Central Index Key (CIK)
0001816590
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
CHESIRE, United Kingdom
State or country of incorporation
United Kingdom
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company
Position in SEC ticker list
#2141 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from COMPASS Pathways plc’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
n/aFY2021n/aFY2022n/aFY2023n/aFY2024n/aFY2025
Net income
-$71.7MFY2021-$91.5MFY2022-$118.5MFY2023-$155.1MFY2024-$287.9MFY2025
CMPS annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue—————
Net income-$71.7M-$91.5M-$118.5M-$155.1M-$287.9M
Diluted EPS-$1.79-$2.16-$2.32-$2.30-$3.08
Total assets$300.9M$197.3M$276.0M$213.7M$210.3M
Cash and equivalents$273.2M$143.2M$220.2M$165.1M$149.6M

XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

CMPS latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 24, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 5, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Apr 15, 2026DEF 14ADefinitive proxy statement· period May 27, 2026Document · Index
Mar 9, 202120-FAnnual report of a foreign private issuer· period Dec 31, 2020Document · Index
Dec 22, 20216-KReport of a foreign private issuer· period Dec 16, 2021Document · Index

Recent SEC filings

The 40 newest documents filed by or about COMPASS Pathways plc, by form type:

4 ×168-K ×8144 ×210-Q ×2SCHEDULE 13G/A ×2S-8 ×2424B5 ×23 ×1S-3ASR ×1ARS ×1DEF 14A ×110-K ×1SCHEDULE 13D/A ×1
CMPS recent filings
FiledFormWhat it isOriginal
Aug 10, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 7, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 5, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026Document · Index
Aug 5, 2026S-3ASRSimplified registration statementDocument · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Aug 5, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 7, 20268-KRegulation FD disclosure; Other events· period Jul 7, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20263Initial statement of beneficial ownership· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 28, 20268-KShareholder vote results· period May 27, 2026Document · Index
May 15, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 13, 20268-KResults of operations· period May 13, 2026Document · Index
May 13, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 15, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 15, 2026DEF 14ADefinitive proxy statement· period May 27, 2026Document · Index
Mar 27, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 26, 2026Document · Index
Mar 27, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 26, 2026Document · Index
Mar 27, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 26, 2026Document · Index
Mar 24, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Mar 24, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Mar 24, 20268-KResults of operations· period Mar 24, 2026Document · Index
Mar 24, 202610-KAnnual report· period Dec 31, 2025Document · Index
Mar 13, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 11, 2026Document · Index
Mar 13, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 11, 2026Document · Index
Mar 3, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 2, 2026Document · Index
Feb 19, 20268-KMaterial agreement; Regulation FD disclosure· period Feb 18, 2026Document · Index
Feb 19, 2026424B5424B5Document · Index
Feb 17, 20268-KRegulation FD disclosure; Other events· period Feb 17, 2026Document · Index
Feb 17, 2026424B5424B5Document · Index
Feb 17, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Feb 3, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 2, 2026Document · Index
Jan 7, 20268-KMaterial agreement; New financial obligation· period Jan 5, 2026Document · Index
Nov 14, 2025SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index

Insider filing activity

17 Form 4 filings appear in COMPASS Pathways plc’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001816590 and XBRL company facts. COMPASS Pathways plc on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.